AbbVie Sued for Corporate Docs Related to Alleged Kickback Scheme
The filing claimed that senior officers and directors had allowed the firm to illegally promote Humira by offering doctors benefits in exchange for prescribing the drug.
May 06, 2019 at 03:49 PM
4 minute read
An investor in AbbVie Inc. has sued the pharmaceutical company in Delaware Chancery Court to investigate an alleged kickback scheme that boosted sales of its popular immunosuppressant Humira and potentially exposed the company to more than $6 billion in legal liability.
The 28-page filing, filed May 3, claimed that senior officers and directors had allowed the firm to illegally promote Humira, which is used to treat rheumatoid arthritis, Crohn's disease and other inflammatory conditions, by offering doctors benefits in exchange for prescribing the drug.
According to the complaint, Humira executives instituted a system of providing incentives to doctors in exchange for prescribing the medication, and created “ambassador ” positions to interact directly with patients and keep them on the drug, which has been linked to increased risks of fatal infections and certain cancers.
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Trending Stories
- 1The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 2Wine, Dine and Grind (Through the Weekend): Summer Associates Thirst For Experience in 'Real Matters'
- 3'That's Disappointing': Only 11% of MDL Appointments Went to Attorneys of Color in 2023
- 4What We Know About the Kentucky Judge Killed in His Chambers
- 5'I'm Staying Everything': Texas Bankruptcy Judge Halts Talc Trials Against J&J
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250